Remdesivir
In study published December 2019, the FDA Data and Safety Monitoring Board (DSMB) stopped the study because it was toxic. Fauci knew this.
Dr. Paul Marik1 on Remdesivir at the 12/18/21 Nashville COVID Summit:
At the first interim analysis, they stopped Remdesivir. Why did they stop the use of Remdesivir? Because this was a toxic drug which killed patients and increased the risk of kidney failure, and the Data Monitoring Safety Board stopped the study because it was toxic. Fauci knew this.
Halfway through the study they did an interim analysis and found that the study was not going to be positive. So they changed the end point, the goal post, halfway through the study. That is called scientific misconduct.
https://www.ntd.com/live-global-covid-summit-nashville-part-2_716402.html
¯\_(ツ)_/¯
Paul E. Marik, M.D., FCCM, FCCP
Endowed Professor of Medicine
Chief, Div. of Pulmonary & Critical Care Medicine
Eastern Virginia Medical School Norfolk, Virginia
https://covid19criticalcare.com/team/paul-e-marik-m-d-fccm-fccp